In Vitro Activities of Ertapenem (MK-0826) against Clinical Bacterial Isolates from 11 North American Medical Centers
- 1 June 2001
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (6) , 1915-1918
- https://doi.org/10.1128/aac.45.6.1915-1918.2001
Abstract
This study compared the in vitro activities of the new long-half-life carbapenem ertapenem (also known as MK-0826 and L-749,345) with those of imipenem, amoxicillin-clavulanate, and ciprofloxacin against 5,558 recent clinical isolates from 11 North American medical centers. We confirmed the greater activity of ertapenem than of imipenem against the Enterobacteriaceae and the greater activity of imipenem against pseudomonads and gram-positive bacteria.Keywords
This publication has 6 references indexed in Scilit:
- In Vitro Activities of the Potent, Broad-Spectrum Carbapenem MK-0826 (L-749,345) against Broad-Spectrum β-Lactamase-and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli Clinical IsolatesAntimicrobial Agents and Chemotherapy, 1999
- In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc testsJournal of Antimicrobial Chemotherapy, 1999
- In Vitro Pharmacodynamic Studies of L-749,345 in Comparison with Imipenem and Ceftriaxone against Gram-Positive and Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 1998
- In Vivo Activity and Pharmacokinetic Evaluation of a Novel Long-Acting Carbapenem Antibiotic, MK-826 (L-749,345)Antimicrobial Agents and Chemotherapy, 1998
- Pharmacokinetics of L-749,345, a long-acting carbapenem antibiotic, in primatesAntimicrobial Agents and Chemotherapy, 1997
- Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogensAntimicrobial Agents and Chemotherapy, 1997